ArticleInternational journal of oncology2014

Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate.

Onika T Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.